Skip to main content

Table 2 Multivariate analysis for PFS

From: Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

 

P Value

95% CI

Lower

Upper

Bevacizumab administration

.275

.466

1.243

ECOG score

.323

.355

1.406

Surgery

.001

1.704

6.973

Age > 65

.413

.769

1.893

NLR

.903

.618

1.724

FIGO stage

.229

.836

1.044

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us